Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02950181 · ClinicalTrials.gov registry record · NA

Descriptive Analysis of Near Infrared Spectroscopy in Critically Ill and Injured Pediatric and Neonatal Patients

A NA study, sponsored by Arkansas Children's Hospital Research Institute.

Terminated
Registry status
NA
Development phase
299
Enrollment target

NCT02950181 is a NA study that was terminated before completion, run by Arkansas Children's Hospital Research Institute. The registered enrollment target is 299 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02950181, a NA study, was terminated before completion, sponsored by Arkansas Children's Hospital Research Institute.

TERMINATED
Registry status
NA
Development phase
299 participants
Enrollment target

Study Summary

This study involves looking at Cerebral oximetry measurements in pediatric and neonatal patients who are experiencing a critical illness. Such as Altered mental status, seizures, trauma, sepsis, etc.

Interventions

  • DEVICE NIRS

Trial Details

FieldValue
Enrollment Target 299 participants
Start Date 2014-07-29
Est. Completion 2019-01-01
Phase NA

What the Registry Record Tells You About NCT02950181

The ClinicalTrials.gov registry entry for NCT02950181 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 299 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Arkansas Children's Hospital Research Institute, which has 97 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which NIRS is the first listed.

NCT02950181 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02950181 about?

NCT02950181 is a clinical study titled "Descriptive Analysis of Near Infrared Spectroscopy in Critically Ill and Injured Pediatric and Neonatal Patients". This study involves looking at Cerebral oximetry measurements in pediatric and neonatal patients who are experiencing a critical illness. Such as Altered mental status, seizures, trauma, sepsis, etc.

What is the current status of trial NCT02950181?

This trial is currently terminated. It is a NA study. The enrollment target is 299 participants. The study started on 2014-07-29. Estimated completion is 2019-01-01.

What interventions are being tested in trial NCT02950181?

The interventions under investigation include: NIRS (DEVICE).

Who is sponsoring clinical trial NCT02950181?

This trial is sponsored by Arkansas Children's Hospital Research Institute, which has 97 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.